Azithromycin to Prevent Pertussis in Household Contacts, Catalonia and Navarre, Spain, 2012-2013

Emerg Infect Dis. 2020 Nov;26(11):2678-2684. doi: 10.3201/eid2611.181418.

Abstract

We retrospectively assessed the effectiveness of azithromycin in preventing transmission of pertussis to a patient's household contacts. We also considered the duration between symptom onset in the primary patient and azithromycin administration. We categorized contacts into 4 groups: those treated within <7 days, 8-14 days, 15-21 days, and >21 days after illness onset in the primary patient. We studied 476 primary index patients and their 1,975 household contacts, of whom 4.5% were later identified as having pertussis. When contacts started chemoprophylaxis within <21 days after the primary patient's symptom onset, the treatment was 43.9% effective. Chemoprophylaxis started >14 days after primary patient's symptom onset was less effective. We recommend that contacts of persons with pertussis begin chemoprophylaxis within <14 days after primary patient's symptom onset.

Keywords: Bordetella pertussis; Spain; antimicrobials; azithromycin; bacteria; chemoprophylaxis; effectiveness; household contacts; pertussis; prevention; respiratory infections.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Antibiotic Prophylaxis*
  • Azithromycin* / therapeutic use
  • Bordetella pertussis
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Infant
  • Male
  • Retrospective Studies
  • Spain / epidemiology
  • Whooping Cough* / drug therapy
  • Whooping Cough* / epidemiology
  • Whooping Cough* / prevention & control
  • Young Adult

Substances

  • Azithromycin